Literature DB >> 31548332

Rhinovirus-Induced SIRT-1 via TLR2 Regulates Subsequent Type I and Type III IFN Responses in Airway Epithelial Cells.

Nathaniel Xander1, Hymavathi Reddy Vari1, Rewees Eskandar1, Wuyan Li1, Sudhir Bolla1, Nathaniel Marchetti1, Umadevi S Sajjan2,3.   

Abstract

IFN responses to viral infection are necessary to establish intrinsic antiviral state, but if unchecked can lead to heightened inflammation. Recently, we showed that TLR2 activation contributes to limitation of rhinovirus (RV)-induced IFN response in the airway epithelial cells. We also demonstrated that compared with normal airway epithelial cells, those from patients with chronic obstructive pulmonary disease (COPD) show higher IFN responses to RV, but the underlying mechanisms are not known. Initially, RV-induced IFN responses depend on dsRNA receptor activation and then are amplified via IFN-stimulated activation of JAK/STAT signaling. In this study, we show that in normal cells, TLR2 limits RV-induced IFN responses by attenuating STAT1 and STAT2 phosphorylation and this was associated with TLR2-dependent SIRT-1 expression. Further, inhibition of SIRT-1 enhanced RV-induced IFN responses, and this was accompanied by increased STAT1/STAT2 phosphorylation, indicating that TLR2 may limit RV-induced IFN responses via SIRT-1. COPD airway epithelial cells showed attenuated IL-8 responses to TLR2 agonist despite expressing TLR2 similar to normal, indicating dysregulation in TLR2 signaling pathway. Unlike normal, COPD cells failed to show RV-induced TLR2-dependent SIRT-1 expression. Pretreatment with quercetin, which increases SIRT-1 expression, normalized RV-induced IFN levels in COPD airway epithelial cells. Inhibition of SIRT-1 in quercetin-pretreated COPD cells abolished the normalizing effects of quercetin on RV-induced IFN expression in these cells, confirming that quercetin exerts its effect via SIRT-1. In summary, we show that TLR2 is required for limiting RV-induced IFNs, and this pathway is dysregulated in COPD airway epithelial cells, leading to exaggerated IFN production.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31548332      PMCID: PMC6810856          DOI: 10.4049/jimmunol.1900165

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrea Faris; Adam Comstock; Wai-Ming Lee; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

2.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

3.  Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Sangbrita S Chattoraj; Asamanja Chattoraj; John R Burgess; Jeffrey L Curtis; Fernando J Martinez; Suzanna Zick; Marc B Hershenson; Uma S Sajjan
Journal:  Respir Res       Date:  2010-09-28

4.  Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice.

Authors:  Dawn C Newcomb; Umadevi S Sajjan; Deepti R Nagarkar; Qiong Wang; Suparna Nanua; Ying Zhou; Christina L McHenry; Kenneth T Hennrick; Wan C Tsai; J Kelley Bentley; Nicholas W Lukacs; Sebastian L Johnston; Marc B Hershenson
Journal:  Am J Respir Crit Care Med       Date:  2008-02-14       Impact factor: 21.405

5.  Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.

Authors:  Patrick Mallia; Simon D Message; Vera Gielen; Marco Contoli; Katrina Gray; Tatiana Kebadze; Julia Aniscenko; Vasile Laza-Stanca; Michael R Edwards; Louise Slater; Alberto Papi; Luminita A Stanciu; Onn M Kon; Malcolm Johnson; Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2010-10-01       Impact factor: 21.405

6.  Quercetin inhibits rhinovirus replication in vitro and in vivo.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Qiong Wang; Suparna Nanua; Marc B Hershenson; Uma S Sajjan
Journal:  Antiviral Res       Date:  2012-03-23       Impact factor: 5.970

7.  Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons.

Authors:  Vera Gielen; Annemarie Sykes; Jie Zhu; Brian Chan; Jonathan Macintyre; Nicolas Regamey; Elisabeth Kieninger; Atul Gupta; Amelia Shoemark; Cara Bossley; Jane Davies; Sejal Saglani; Patrick Walker; Sandra E Nicholson; Alexander H Dalpke; Onn-Min Kon; Andrew Bush; Sebastian L Johnston; Michael R Edwards
Journal:  J Allergy Clin Immunol       Date:  2015-01-25       Impact factor: 10.793

8.  Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.

Authors:  Darren J Perkins; Swamy K Polumuri; Meghan E Pennini; Wendy Lai; Ping Xie; Stefanie N Vogel
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

9.  Pathogenic potential of interferon αβ in acute influenza infection.

Authors:  Sophia Davidson; Stefania Crotta; Teresa M McCabe; Andreas Wack
Journal:  Nat Commun       Date:  2014-05-21       Impact factor: 14.919

Review 10.  Type I Interferons as Regulators of Lung Inflammation.

Authors:  Spyridon Makris; Michelle Paulsen; Cecilia Johansson
Journal:  Front Immunol       Date:  2017-03-10       Impact factor: 7.561

View more
  5 in total

Review 1.  Rhinovirus and Innate Immune Function of Airway Epithelium.

Authors:  Haleh Ganjian; Charu Rajput; Manal Elzoheiry; Umadevi Sajjan
Journal:  Front Cell Infect Microbiol       Date:  2020-06-19       Impact factor: 5.293

Review 2.  Cellular and functional heterogeneity of the airway epithelium.

Authors:  Jordan D Davis; Tomasz P Wypych
Journal:  Mucosal Immunol       Date:  2021-02-19       Impact factor: 8.701

3.  Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation.

Authors:  Xiaoming Liu; Xiang Li; Ling Chen; Alan Chen-Yu Hsu; Kelly L Asquith; Chi Liu; Karen Laurie; Ian Barr; Paul S Foster; Ming Yang
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

4.  Distinct Antiviral Properties of Two Different Bacterial Lysates.

Authors:  Michael Roth; Hanif J Khameneh; Lei Fang; Michael Tamm; Giovanni A Rossi
Journal:  Can Respir J       Date:  2021-02-04       Impact factor: 2.409

5.  Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation.

Authors:  Anet Laanesoo; Egon Urgard; Kapilraj Periyasamy; Martti Laan; Yury A Bochkov; Alar Aab; Nathaniel Magilnick; Margus Pooga; James E Gern; Sebastian L Johnston; Jonathan M Coquet; Mark P Boldin; Jesper Wengel; Alan Altraja; Grazyna Bochenek; Bogdan Jakiela; Ana Rebane
Journal:  Clin Transl Med       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.